about
Genetic variants of miRNA sequences and non-small cell lung cancer survivalFucoidans in NanomedicineMicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesPolymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic reviewNanotheranostics for personalized medicineNew insights in bilirubin metabolism and their clinical implicationsDoes your gene need a background check? How genetic background impacts the analysis of mutations, genes, and evolutionCombinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphismsHaemophilia management: time to get personal?Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.How effective is tetracaine 4% gel, before a peripherally inserted central catheter, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial [ISRCTN75884221].A survey of genomic properties for the detection of regulatory polymorphisms.Genotyping panel for assessing response to cancer chemotherapy.Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.Genetic variation of the IL-28B promoter affecting gene expression.Rapid-learning system for cancer care.Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.Pharmacogenomics: the genetics of variable drug responses.Pharmacogenomic technologies: a necessary "luxury" for better global public health?Functional characterization of liver enhancers that regulate drug-associated transporters.Bioinformatics and variability in drug response: a protein structural perspective.Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine.Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine.Applications of microfluidics and microchip electrophoresis for potential clinical biomarker analysis.Protein therapeutics: new applications for pharmacogenetics.Validation of tacrolimus equation to predict troughs using genetic and clinical factors.Molecular markers for gastric adenocarcinoma: an update.Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy.Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision.Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.Pharmacogenetics of analgesics: toward the individualization of prescription.Engineered polymers for advanced drug delivery.Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine.A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain.Personalized echocardiography: clinical applications of advanced echocardiography and future directions.Transcriptional regulation and pharmacogenomics.Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets.On the readiness of physicians for pharmacogenomics testing: an empirical assessment.
P2860
Q24648054-2DA7CD8D-A971-429F-9239-5288CF312623Q26739976-69ECB721-8DE9-402A-A5E1-1A686FF978D4Q26750448-5F42F3DB-4EE2-480D-9545-ED6C37CEEC70Q26824719-55FA4A65-667F-4A0D-99ED-B8593F37ED37Q26851449-A12B0966-16B6-4BD9-93BB-857D06B70FF9Q26863145-F69C5162-3531-4CFF-8E5E-845911B594DAQ27693280-F870F75D-68AD-427A-B664-9DBA984270CCQ28484344-B7C61A70-EB26-4E14-99EB-130BB9FEF7FCQ30403530-B06E7F4E-A4F2-4BDC-803B-70B669F28898Q30436623-E596E209-1E1F-4C18-A56B-B67FFD0DB2DCQ33242106-D02B77EE-E8DA-44D1-94D5-F165FBD1A556Q33287187-ACA63FB8-9151-4E8A-B9F0-0C9822BC1F9BQ33343095-95551470-973D-4BBD-998D-C3F33C6D701BQ33480591-7E3613D3-6B81-4EFE-B161-26B993C5F063Q33771570-5F252624-523D-4880-9B2B-21B606DA9158Q34064550-581ADD37-8686-48C3-8E93-5FCEFF988EAFQ34193994-3ABF6466-1805-4481-8F87-2B44188E6725Q34697234-32B7EA9A-94F2-46B9-A244-DA0C178AB4A5Q34976915-36622084-4317-4EBB-9512-E4BBEDB27332Q35219458-FC92100B-FF3E-4299-BCE9-DA838DF1266EQ35583006-45A6DB4A-E52A-4C83-BB93-D5D4D37D047EQ36009999-D22BDFCF-58BD-45AF-9C5C-8E38F1605CC7Q36441457-CFFFD842-EFC7-41B1-A646-658EB42890C4Q36441465-A9CAF2BE-A3CF-47FD-8A01-3015CD6441AAQ36496717-3037AC74-5BE0-48C6-92A1-E552BEA96BD7Q36501235-2483413C-0E51-4973-BF8E-30D6AE4C10BBQ36630077-9C748BD9-5F89-4170-87DA-6E30CC11E939Q36677268-F58E35B0-C07D-4EC6-9A73-FD7D54A2AC67Q36745681-EEA48729-3943-4DC7-9868-1765762673A2Q37034397-782C7635-0EFD-40F7-A02D-902E320EE784Q37160674-55459B27-3E6F-4424-A657-375751226ECDQ37205951-928FF65E-0842-4FCA-8548-61ECE1A7B181Q37205954-19B88243-710B-46FF-861A-675E34BCA4D5Q37314701-EE6C79A9-A15D-4BB8-BDE3-BEED573D72D7Q37365172-78F8A9E4-E19D-4A94-BAE6-FB4F08AF1DBEQ37422855-6B575C77-786A-448C-BF74-464EE1DD7420Q37818213-77E620B3-6EDF-4166-8D1C-BAAD4989CE32Q37880878-B074A553-93D2-44B2-920C-AC3A1BA9ED40Q38187948-A03C4F3D-E262-4FAD-9120-A1178BB69DE9Q38728697-CC9528C1-92B2-4C9A-B149-600E1C506786
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pharmacogenetics/genomics and personalized medicine.
@ast
Pharmacogenetics/genomics and personalized medicine.
@en
type
label
Pharmacogenetics/genomics and personalized medicine.
@ast
Pharmacogenetics/genomics and personalized medicine.
@en
prefLabel
Pharmacogenetics/genomics and personalized medicine.
@ast
Pharmacogenetics/genomics and personalized medicine.
@en
P2860
P356
P1476
Pharmacogenetics/genomics and personalized medicine.
@en
P2093
Wolfgang Sadée
Zunyan Dai
P2860
P304
P356
10.1093/HMG/DDI261
P478
14 Spec No. 2
P577
2005-10-01T00:00:00Z